Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00VQT
|
|||
| Former ID |
DIB015686
|
|||
| Drug Name |
99mTc-EC-DG
|
|||
| Synonyms |
EC-DG-[99mTc]; Technetium-99m-EC-DG; Technetium-99m-EC-G; Technetium-99m-EC-deoxyglucose; Technetium-99m-ethylenedicysteine-glucosamine; 99mTc-EC-G; 99mTc-EC-deoxyglucose; 99mTc-ethylenedicysteine-glucosamine; 99mTechnetium-EthylenediCysteine-n-acetyl-Glucosamine
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 3 | [1] | |
| Company |
Cell>Point LLC
|
|||
| Structure |
 |
Download2D MOL
|
||
| Formula |
C20H34N4O13S2Tc
|
|||
| Canonical SMILES |
C(C[N-]C(C[S-])C(=O)NC1C(C(C(OC1O)CO)O)O)[N-]C(C[S-])C(=O)NC2C(C(C(OC2O)CO)O)O.O=[Tc+4]
|
|||
| InChI |
1S/C20H36N4O12S2.O.Tc/c25-3-9-13(27)15(29)11(19(33)35-9)23-17(31)7(5-37)21-1-2-22-8(6-38)18(32)24-12-16(30)14(28)10(4-26)36-20(12)34;;/h7-16,19-20,25-30,33-34,37-38H,1-6H2,(H,23,31)(H,24,32);;/q-2;;+4/p-2
|
|||
| InChIKey |
XUWZVUPFDWQUTO-UHFFFAOYSA-L
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01394679) A Phase 3 Study of 99mTC-EC-DG SPECT/CT Versus PET/CT in Lung Cancer. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.